Eletriptan clinical trials
How each study uses eletriptan is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Get an email when these change. Save the eletriptan studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.
See an example email
Example · made-up studies
Breast cancer · Recruiting: 2 came in, 3 changed
What changed in your alerts, Oct 31 – Nov 6:
A study of drug A after surgery for early breast cancer
Came in · now Recruiting
Drug B with hormone therapy in advanced breast cancer
Changed
· Sites: 4 added, including Seoul and Busan
· Enrollment: 300 → 450 participants
Exercise during chemotherapy
Now Active, not recruiting
One email a week for all your alerts. Stop any time.
Approvals
The first approval found in each region, with its record
- United States
- 26 Dec 2002 · RELPAX · NDA 021016 (FDA, Drugs@FDA)
- European Union
- Not in EMA's list of EU-wide authorizations
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
How studies write it
Studies that test it under each name
Studies by the year they started
12 studies that test it; most in 1996 (3)
| Year | Studies |
|---|---|
| 1996 | 3 |
| 1999 | 1 |
| 2000 | 1 |
| 2002 | 1 |
| 2003 | 1 |
| 2004 | 1 |
| 2005 | 1 |
| 2006 | 1 |
| 2008 | 1 |
| 2025 | 1 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it, so a study counts once.
Who runs them
Industry 10 · Other 2
Pfizer's Upjohn has merged with Mylan to form Viatris Inc. (8) · GlaxoSmithKline (1) · University of Pittsburgh (1) · California Medical Clinic for Headache (1) · Technophage, SA (1)
Often tested with
Tested in the same studies.
Related medicines
As reviewed, each with the page that says it.
Coming up
From the study records. Dates are the sponsors’ own estimates and often move.
Reaching primary completion within a year · 1
Studies that test eletriptan.
- Dec 2026Phase 1b/2a Clinical Trial to Determine the Safety, Tolerability and Efficacy of TZ-161 in Spinal Cord InjuryPhase 1/2 · Technophage, SA
Studies
Open first, then newest update. How each study uses eletriptan is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 12
- Phase 1b/2a Clinical Trial to Determine the Safety, Tolerability and Efficacy of TZ-161 in Spinal Cord InjuryRecruitingPhase 1/2Technophage, SANCT06677229Written as Eletriptan HBr 40 mg
- Efficacy, Safety, and Tolerability of Oral Eletriptan for Treatment of Acute MigraineCompletedPhase 3Pfizer's Upjohn has merged with Mylan to form Viatris Inc.NCT01978496Written as Eletriptan 20 mg
- Comparative Study of Oral Eletriptan (40mg and 80mg), Oral Sumatriptan (25mg and 50mg) and PlaceboCompletedPhase 3Pfizer's Upjohn has merged with Mylan to form Viatris Inc.NCT01986270Written as Eletriptan 40 mg
- Eletriptan vs Sumatriptan: A Double-blind, Placebo-controlled, Multiple Migraine Attack StudyCompletedPhase 3Pfizer's Upjohn has merged with Mylan to form Viatris Inc.NCT01986088Written as Eletriptan 40 mg
- Eletriptan Provides Consistent Migraine Relief: Results Of A Within-Patient Multiple-Dose StudyCompletedPhase 3Pfizer's Upjohn has merged with Mylan to form Viatris Inc.NCT01859481Written as Eletriptan HBr 40 mg
- A Trial to Study of the Effects of Eletriptan 40mg on Mild vs Moderate to Severe Pain Intensity of MigraineCompletedPhase 4Pfizer's Upjohn has merged with Mylan to form Viatris Inc.NCT00174395Written as eletriptan
- Eletriptan for the Treatment of Migraine in Patients With Previous Poor Response or Tolerance to Oral SumatriptanCompletedPhase 3Pfizer's Upjohn has merged with Mylan to form Viatris Inc.NCT01989936Written as Eletriptan 40 mg
- Safety and Efficacy of Eletriptan for the Treatment of Migraine in Subjects Unsuccessfully Treated With Nonsteroidal Anti-inflammatory DrugsCompletedPhase 4Pfizer's Upjohn has merged with Mylan to form Viatris Inc.NCT00634985Written as eletriptan
- Efficacy and Safety of Eletriptan for the Treatment of Migraine in Patients Not Satisfied With Rizatriptan TherapyCompletedPhase 4Pfizer's Upjohn has merged with Mylan to form Viatris Inc.NCT00632385Written as Eletriptan
- TREXIMA and RELPAX Gastric Scintigraphy Inside and Outside a MigraineCompletedPhase 3GlaxoSmithKlineNCT00385008Written as RELPAX(eletriptan) 40mg Tablet
- Prospective Survey of Menstrual Migraine & Prevention With EletriptanCompletedPhase 4University of PittsburghNCT00259649Written as eletriptan
- Zolmitriptan Nasal Spray Versus Eletriptan in the Acute Treatment of MigraineCompletedNot applicableCalifornia Medical Clinic for HeadacheNCT01276977Written as Eletriptan 40 mg tablet
As the comparator · 1 — what is tested is compared with eletriptan
Codes
What other systems call eletriptan · ClinicalTrials.gg INT004114
- MeSH (NLM) C115647eletriptanConfirmed ClinicalTrials.gov, NLM, Wikidata
- UNII (FDA) 22QOO9B8KIELETRIPTANConfirmed FDA, NLM, Wikidata
- RxNorm 231049Confirmed FDA, Wikidata
- Wikidata Q415032eletriptanConfirmed FDA, NLM, Wikidata
- NCI Thesaurus C65509EletriptanOne source FDA
- DrugBank DB00216One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | C115647 | eletriptan | Confirmed ClinicalTrials.gov, NLM, Wikidata |
| UNII (FDA) | 22QOO9B8KI | ELETRIPTAN | Confirmed FDA, NLM, Wikidata |
| RxNorm | 231049 | — | Confirmed FDA, Wikidata |
| Wikidata | Q415032 | eletriptan | Confirmed FDA, NLM, Wikidata |
| NCI Thesaurus | C65509 | Eletriptan | One source FDA |
| DrugBank | DB00216 | — | One source Wikidata |
Also registered as eletriptan hydrobromide (UNII M41W832TA3 · RxNorm 360288).
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.